Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze SGLOF stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate SGLOF investment potential.

What is SGLOF stock price today?

Get real-time SGLOF stock price, historical data, and price charts on Financhill. Track SGLOF performance with our advanced analysis tools.

Is SGLOF a good investment?

Evaluate SGLOF investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy SGLOF stock?

To buy SGLOF stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of SGLOF?

View detailed market capitalization data and company valuation metrics for SGLOF on our comprehensive analysis page.

What is the P/E ratio of SGLOF?

Use our fundamental analysis tools to view SGLOF P/E ratio and compare valuation metrics with industry peers.

What are SGLOF earnings?

View SGLOF earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

FOOD & LIFE COMPANIES LTD. 10K Form

Buy

100

SGLOF
FOOD & LIFE COMPANIES LTD.

Last Price:

$17.82

Seasonality Move:

5.05%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SGLOF News And Ratings

See the #1 stock for the next 7 days that we like better than SGLOF

SGLOF Financial Statistics

Sales & Book Value

Annual Sales:	$2.9B
Cash Flow:	$52.2M
Price / Cash Flow:	22.89
Annual Sales:	$5.88
Price / Book:	10.01

Profitability

EPS (TTM):	1.47290
Net Income (TTM):	$181.1M
Gross Margin:	$1.4B
Return on Equity:	28.78%
Return on Assets:	7.03%

FOOD & LIFE COMPANIES LTD. Earnings Forecast

Key FOOD & LIFE COMPANIES LTD. Financial Ratios

The Gross Profit Margin over the past 11 years for SGLOF is 48.72%.
The Selling, General & Administrative Expenses for SGLOF have been equal to 48.57% of Gross Profit Margin.
The Research & Development expenses have been 0.00% of Revenue.
The Interest Expense is 10.86% of Operating Income.
The Net Earning history of SGLOF is 5.73% of Total Revenues.
Per Share Earnings over the last 11 years have been positive in 7 years.

FOOD & LIFE COMPANIES LTD. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	OTCM
Industry:	Hotels, Restaurants & Leisure
Sector:	Consumer Discretionary
Current Symbol:	SGLOF
Website:	sushiroglobalholdings.com

Debt

Debt-to-Equity Ratio:	2.14
Current Ratio:	1.04
Quick Ratio:	0.86

Price-to-Earnings

Trailing P/E Ratio:	44.01
Forward P/E Ratio:	0

SGLOF Technical Analysis vs Fundamental Analysis

Buy

100

FOOD & LIFE COMPANIES LTD. (SGLOF) is a Buy

Is FOOD & LIFE COMPANIES LTD. a Buy or a Sell?

FOOD & LIFE COMPANIES LTD. stock is rated a Buy

The current FOOD & LIFE COMPANIES LTD. [SGLOF] share price is $59.00. The Score for SGLOF is 100, which is 100% above its historic median score of 50, and infers lower risk than normal.